Conclusions
In conclusion,
the
new lisinopril/amlodipinebesylate FDC product(specification: lisinopril
10mg / amlodipine 5mg)developed by Sichuan Sunrise Biopharm Co. Ltd
(Sichuan Province, China)are equivalent to the Lisonorm (specification:
lisinopril 10mg / amlodipine 5mg) produced by Gedeon Richter Ltd
(Hungary). If the test formulation can be approved by NMPA, it can be
used in the treatment of hypertension in Chinese adult patients.
However, patients may need to avoid consumption of high-fat,
high-calorie diet during treatment.